Evaluation of the reversal of multidrug resistance by mdr1 ribonucleic acid interference in a human colon cancer model using a renilla luciferase reporter gene and coelenterazine

Molecular Imaging

Volumn 9, Issue 6, 2010, Pages 343-350

  Jeon, Yong Hyun ^a,b   Bae, Seon Ae ^a,b   Lee, Yong Jin ^a,b   Lee, You La ^a,b   Lee, Sang Woo ^a,b   Yoon, Ghil Suk ^a,b   Ahn, Byeong Cheol ^a,b   Ha, Jeoung Hee ^a,b   Lee, Jaetae ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRAL VECTORS; ANIMAL MODEL; BIOLUMINESCENCE IMAGING; BIOLUMINESCENT IMAGING; COEXPRESSED; DOSE-DEPENDENT MANNER; GREEN FLUORESCENT PROTEIN; HUMAN COLON CANCER; IN-CONTROL; IN-VIVO; MULTIDRUG RESISTANCE; MULTIPLICITY OF INFECTIONS; P-GLYCOPROTEIN; RECOMBINANT ADENOVIRUS; RENILLA LUCIFERASE; REPORTER GENE; RIBONUCLEIC ACID; SIGNAL INTENSITIES;

ACIDS; ANIMALS; BIOLUMINESCENCE; FLUORESCENCE; GLYCOPROTEINS; MICROSCOPIC EXAMINATION; RNA; TUMORS; VIRUSES;

GENE EXPRESSION;

ABCB1 PROTEIN, HUMAN; COELENTERAZINE; CYCLOSPORIN; GLYCOPROTEIN P; IMIDAZOLE DERIVATIVE; PYRAZINE DERIVATIVE; RENILLA LUCIFERIN 2 MONOOXYGENASE; SMALL INTERFERING RNA;

ADENOVIRUS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; COLON TUMOR; DRUG RESISTANCE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUMINESCENCE; METABOLISM; MOUSE; MULTIDRUG RESISTANCE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLOSPORINE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENES, REPORTER; HUMANS; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; LUCIFERASES, RENILLA; LUMINESCENT MEASUREMENTS; MICE; MODELS, BIOLOGICAL; P-GLYCOPROTEIN; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 78649754608     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00021     Document Type: Article

References (13)

1. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003;55:3-29.
2. Hannon GJ. RNA interference. Nature 2002;418:244-51.
3. Kaszubiak A, Holm PS, Lage H. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti- MDR1 short hairpin RNAs and ribozymes. Int J Oncol 2007;31: 419-30.
4. Jang JY, Choi Y, Jeon YK, et al. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo. Breast Cancer Res 2008;10:R11.
5. Kang JH, Chung JK. Molecular-genetic imaging based on reporter gene expression. J Nucl Med 2008;49 Suppl 2:164S-79S.
6. Pichler A, Prior JL, Piwnica-Worms D. Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine. Proc Natl Acad Sci U S A 2004;101:1702-7.
7. Piwnica-Worms D, Rao VV, Kronauge JF, et al. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 1995;34:12210-20.
8. Wu H, Hait WN, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003;63:1515-9.
9. Ye X, Liu T, Gong Y, et al. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Leuk Res 2009;33:1114-9.
10. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
11. Ciarmiello A, Del Vecchio S, Silvestro P, et al. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 1998;16:1677-83.
12. Agrawal M, Abraham J, Balis FM, et al. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res 2003;9:650-6.
13. Ballinger JR. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein. Cancer Biother Radiopharm 2001;16:1-7.